Metabolic approach to myocardial ischemia: a novel therapeutic strategy for patients with coronary artery disease?
Rizzon
P
P
Istituto di Cardiologia, Universita degli Studi, Bari.
Iliceto
S
S
Marangelli
V
V
D000083:Acetanilides; D002331:Carnitine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003067:Coenzymes; D003327:Coronary Disease / Q000188:drug therapy* / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D017202:Myocardial Ischemia / Q000188:drug therapy / Q000378:metabolism*; D010879:Piperazines / Q000627:therapeutic use; D000069458:Ranolazine; D013482:Superoxide Dismutase / Q000627:therapeutic use; D014292:Trimetazidine / Q000627:therapeutic use; D014451:Ubiquinone / Q000031:analogs & derivatives / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000083:Acetanilides; D003067:Coenzymes; D004791:Enzyme Inhibitors; D010879:Piperazines; D014665:Vasodilator Agents; D014451:Ubiquinone; D000069458:Ranolazine; D013482:Superoxide Dismutase; C024989:coenzyme Q10; D014292:Trimetazidine; D002331:Carnitine